Top Markets
Coin of the day
Harbin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd.

600664
Clasificación en acciones #4980
Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical... Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical company, overseeing the complete process from drug discovery and development to manufacturing and global sales. The firm's activities span both domestic Chinese markets and international territories. Its business structure is segmented into seven key areas: Antibiotics, Small-Molecule Drug Formulations, Over-the-Counter (OTC) and Health Products, Modern Chinese Medicine, Biopharmaceutical products, Animal Vaccines, and Pharmaceutical Distribution services. The company's broad product portfolio features a comprehensive selection of penicillin and cephalosporin antibiotics, in addition to vital pharmaceutical intermediates. Its notable offerings include various types of injections, such as Shuang Huanglian and Danshen freeze-dried injections, alongside a wide array of oral medications like roxithromycin dispersible tablets, amoxicillin capsules, and specialized pediatric granules containing paracetamol. The product line also encompasses a diverse range of antibiotics, highlighted by multiple cephalosporin-based injections (e.g., ceftriaxone sodium, cefepime hydrochloride) and penicillin derivatives, alongside extracts from traditional Chinese medicine like Panax ginseng. Furthermore, the group manufactures essential medical protective gear, including disposable surgical and protective masks, as well as isolation and protective gowns. These products are distributed under numerous well-known brands, including Hongyan Yaopin, Guangwei, Renmin Tongtai, and Hayao, among others. The company's headquarters are located in Harbin, China.
Precio por acción
$1.23
Capitalización bursátil
$3.11B
Cambio (1 día)
4.03%
Cambio (1 año)
133.40%
País
CN
Comercio Harbin Pharmaceutical Group Co., Ltd. (600664)

Categoría

Ratio P/S de Harbin Pharmaceutical Group Co., Ltd. (600664)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Harbin Pharmaceutical Group Co., Ltd., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Harbin Pharmaceutical Group Co., Ltd. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras